Healthcare costs in patients with metastatic lung cancer receiving chemotherapy

BACKGROUND: To characterize healthcare resource utilization and costs in patients with metastatic lung cancer receiving chemotherapy in the US. METHODS: Using data from a large private multi-payer health insurance claims database (2000-2006), we identified all patients beginning chemotherapy for met...

Descripción completa

Detalles Bibliográficos
Autores principales: Vera-Llonch, Montserrat, Weycker, Derek, Glass, Andrew, Gao, Sue, Borker, Rohit, Barber, Beth, Oster, Gerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239411/
https://www.ncbi.nlm.nih.gov/pubmed/22074001
http://dx.doi.org/10.1186/1472-6963-11-305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3239411/
https://www.ncbi.nlm.nih.gov/pubmed/22074001
http://dx.doi.org/10.1186/1472-6963-11-305

Ejemplares similares